T1	Participants 29 49	rheumatoid arthritis
T2	Participants 227 262	patients with rheumatoid arthritis.
T3	Participants 380 545	Two hundred and one functional class I and II patients with definite or classic rheumatoid arthritis, previously untreated with disease modifying antirheumatic drugs
T4	Participants 2146 2187	patients with active rheumatoid arthritis
T5	Participants 2280 2313	inflammatory, autoimmune diseases
